Online GLP-1 Programs in Vermont
Vermont has one of the lowest obesity rates in the country, and its Medicaid program does not cover GLP-1s for weight loss, only for diabetes and certain heart-related uses. In a heavily rural state, most residents reach semaglutide and tirzepatide for weight loss through cash-pay or telehealth.
Population
648K
49th-largest state
Adult obesity
29.0%
2024 BRFSS
Diagnosed diabetes
9.0%
2023 BRFSS
Medicaid (weight loss)
Not coveredFrom $129/mo · Ships in 2–4 days · Sponsored
Insurance
Does Vermont Medicaid cover GLP-1s?
Vermont Medicaid (Green Mountain Care) does not cover GLP-1s for weight loss; the state's Medicaid plan explicitly excludes these drugs for weight loss (KFF, 2026; Real Chemistry, 2025). Wegovy is covered narrowly for cardiovascular-risk reduction in adults with established heart disease, not for obesity itself. GLP-1s for type 2 diabetes are covered, as federal law requires.
Online Access
Getting a GLP-1 online in Vermont
GLP-1s are not controlled substances, so Vermont allows them to be prescribed via telehealth, though an out-of-state clinician treating a Vermont patient must hold a Vermont license or telehealth registration. Given Vermont's heavily rural geography, telehealth is an important route for residents seeking these drugs.
Compounding
Compounded semaglutide & tirzepatide in Vermont
Routine compounding of semaglutide and tirzepatide ended after the FDA resolved the shortages in early 2025 (FDA, 2025). Vermont adds no special carve-out beyond the federal 503A/503B framework, so compounding is limited to documented, patient-specific clinical need.
Demand
Where GLP-1 demand is highest in Vermont
About 29% of Vermont adults have obesity, among the lowest rates in the country, and roughly 9% have diagnosed diabetes (CDC BRFSS and Vermont Department of Health, 2023 to 2024). Demand concentrates in the Burlington area, the state's only sizable metro. As the second-least populous and a heavily rural state, Vermont relies on telehealth for access, which is also the main route for weight-loss GLP-1s that Medicaid does not cover.
Questions
Vermont GLP-1 FAQ
Does Vermont Medicaid cover Wegovy or Zepbound?
Not for weight loss. Vermont Medicaid's plan excludes GLP-1s for weight loss, though Wegovy is covered narrowly for cardiovascular risk and GLP-1s are covered for type 2 diabetes (KFF, 2026; Real Chemistry, 2025).
Can I get a GLP-1 prescribed online in Vermont?
Yes, by a Vermont-licensed clinician or one with a Vermont telehealth registration. GLP-1s are not controlled substances, and telehealth is common given Vermont's rural geography.
Is compounded tirzepatide available in Vermont?
Only narrowly. Routine compounding ended after the FDA resolved the shortages in 2025, and Vermont follows the federal rules with no special carve-out.
Compound Guides
The GLP-1s behind these programs
Sources
How we sourced this page
Coverage, prevalence, and policy figures are drawn from primary and authoritative sources, last reviewed June 2026.
- 1.KFF — Medicaid Coverage of and Spending on GLP-1s (Jan 2026)
- 2.Real Chemistry — state-by-state Medicaid GLP-1 analysis (Vermont weight-loss exclusion)
- 3.America's Health Rankings — Vermont obesity (CDC BRFSS 2024)
- 4.Vermont Department of Health — 2023 BRFSS report (diabetes)
- 5.Vermont Statutes 18 V.S.A. § 9361 — telehealth prescribing
- 6.FDA — Compounding policy as GLP-1 supply stabilizes (2025)
Telehealth, no insurance needed
Personalized GLP-1 for Vermont residents
Skip the coverage maze. Yucca Health connects Vermont residents with US-licensed clinicians for personalized GLP-1 treatment, from $129/mo.
See if you qualifySponsored · Affiliate disclosure
Educational information only, not medical or legal advice and not a substitute for a licensed clinician. GLP-1 coverage, telehealth, and compounding rules vary by state and change frequently; verify the current rules for your state before starting treatment. Links to Yucca Health are sponsored. Last reviewed 2026-06-13.